Local Infiltration Analgesia in Major Spine Surgery With Ropivacaine Versus Placebo
NCT ID: NCT00771459
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
48 participants
INTERVENTIONAL
2008-10-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Wound Infusion in Lumbar or Thoracic Surgery
NCT01743794
Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery
NCT02201784
A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery
NCT01117610
Erector Spine Block for Back Surgery
NCT03214536
Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters
NCT01559285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine
Ropivacaine 0.5 %
Local infiltration analgesia
Placebo
Isotonic NaCl
Local infiltration analgesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine 0.5 %
Local infiltration analgesia
Isotonic NaCl
Local infiltration analgesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must speak and understand Danish
* must be able to give oral and written consent
Exclusion Criteria
* treatment with opioids \> 100 mg daily
* allergy to local anesthetics
* severe obesity
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hvidovre University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hvidovre University Hospital
Copenhagen, Hvidovre, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-D-2007-0111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.